Historical Impact

DARPA (Defense Advanced Research Projects Agency) has been essential to BCI development for decades, funding foundational research that established technological feasibility before commercial companies entered the space. Many current commercial BCIs trace their scientific roots directly to DARPA-funded research programs.

Revolutionizing Prosthetics Program

The Revolutionizing Prosthetics programme, launched in 2006, funded two advanced prosthetic arms: the LUKE Arm, developed by DEKA Research and Development and cleared by the FDA in May 2014, and the Modular Prosthetic Limb, a research arm built by the Johns Hopkins University Applied Physics Laboratory. The programme also developed direct neural control. Volunteers with paralysis used electrode arrays placed on their brains to control the Modular Prosthetic Limb, and a 2016 study returned touch sensation from the arm’s sensors to a volunteer’s brain.

Neural Engineering System Design

DARPA’s Neural Engineering System Design (NESD) program advanced the state-of-the-art in miniaturized neural recording electrodes and wireless power delivery to implanted devices. Many current commercial technologies incorporate innovations funded through NESD research.

Funding Leverage

DARPA funding has often been instrumental in proving technological feasibility at a level sufficient to attract venture capital investment. Commercial companies like Paradromics explicitly receive complementary DARPA grants alongside venture funding, leveraging government resources to de-risk development timelines.

Ongoing Support

DARPA continues funding BCI research alongside commercial company development, maintaining a government role in advancing foundational technologies that benefit the entire sector. This public-private research model has proven effective in accelerating neurotechnology deployment. In 2026 DARPA opened new neurotechnology programmes including O-CIRCUIT (biological processing units built from neural organoids, April), SHINE (non-invasive neuroplasticity, Defense Sciences Office, August) and Firefox (a 100-channel non-invasive optical BCI, Biological Technologies Office, August).